Renasant Bio
PrivateLast Round
Seed
Jul 10, 2025
Total Funding Raised
$54.5M
Momentum Score
25 /100
Company Overview
Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments for autosomal dominant polycystic kidney disease (ADPKD).
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Renasant Bio Comps
Public and private peers based on sector, stage, and business model.
Renasant Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 10, 2025 |
Renasant Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OrbiMed | Seed |
| 5AM Ventures | Seed |
| Qiming | Seed |
| Atlas Venture | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 12, 2025
Based out of the Bakar Labs incubator in Berkeley, CA.
- Jul 10, 2025
$55M raised in Seed round.
Renasant Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Renasant Bio's valuation, stock price, and market status.
